CELC
USDCelcuity Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$12.320
High
$12.770
Low
$12.320
Volume
0.13M
Company Fundamentals
Market Cap
476.0M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.23M
Exchange
NCM
Currency
USD
52-Week Range
Related News
HC Wainwright & Co. Reiterates Buy on Celcuity, Maintains $27 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Celcuity with a Buy and maintains $27 price target.
Needham Reiterates Buy on Celcuity, Maintains $29 Price Target
Needham analyst Gil Blum reiterates Celcuity with a Buy and maintains $29 price target.
Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
The primary completion date of the PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is expected in June 2025 and a topline data readout is anticipated in the third quarter of 2025 Enrollment is ongoing in the
Celcuity Inc. Schedules Release of First Quarter 2025 Financial Results and Webcast/Conference Call
MINNEAPOLIS, May 07, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.